COVID-19 and cardiovascular disease: What we know, what we think we know, and what we need to know-Reference-Cited by-同舟云学术

COVID-19 and cardiovascular disease: What we know, what we think we know, and what we need to know

Published:2020-07 Issue: Volume:144 Page:12-14
ISSN:0022-2828
Container-title:Journal of Molecular and Cellular Cardiology
language:en
Short-container-title:Journal of Molecular and Cellular Cardiology

Author:

Dhawan Rahul,Gundry Rebekah L.,Brett-Major David M.,Mahr Claudius,Thiele Geoffrey M.,Lindsey Merry L.,Anderson Daniel R.

Funder

National Institutes of Health

Juvenile Diabetes Research Foundation

Biomedical Laboratory Research and Development Service

Veterans Affairs Office of Research and Development

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,Molecular Biology

Reference11 articles.

1. Receptor recognition by the novel coronavirus from Wuhan: an analysis based on decade-long structural studies of SARS coronavirus;Wan;J. Virol.,2020

2. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor;Hoffmann;Cell,2020

3. Angiotensin-converting enzyme 2 protects from severe acute lung failure;Imai;Nature,2005

4. Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2;Ferrario;Circulation,2005

5. Angiotensin converting enzyme 2 activity and human atrial fibrillation: increased plasma angiotensin converting enzyme 2 activity is associated with atrial fibrillation and more advanced left atrial structural remodelling;Walters;Ep Europace,2017

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Changes in Adenosine Deaminase Activity and Endothelial Dysfunction after Mild Coronavirus Disease-2019;International Journal of Molecular Sciences;2023-08-24

2. Accelerating drug repurposing for COVID-19 treatment by modeling mechanisms of action using cell image features and machine learning;Cognitive Neurodynamics;2021-11-05

3. In-hospital prognostic role of coronary atherosclerotic burden in COVID-19 patients;Journal of Cardiovascular Medicine;2021-07-13

4. Infarct in the Heart: What’s MMP-9 Got to Do with It?;Biomolecules;2021-03-25

5. Risk factors for severe illness and death in COVID-19: a systematic review and meta-analysis;2020-12-04